Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Randomized, Double-Blind, Placebo-Controlled Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03539887

Organisation Name: The University of Texas Health Science Center, Houston

Overal Status: Recruiting

Start Date: May 1, 2018

Last Update: July 13, 2021

Lead Sponsor: The University of Texas Health Science Center, Houston

Brief Summary: This project aims to evaluate the potential rapid and sustained antisuicidal and antidepressant effects of a single intranasal dose of ketamine in inpatients during a mood episode in Major Depressive Disorder (MDD) or Bipolar Disorder (BD) with or without comorbid recent abuse of alcohol.

Conditions:
  • Suicidal Ideation
  • Depression
  • Alcohol Abuse


Total execution time in seconds: 0.24040007591248